The Asian Oncology Society 1st Virtual International Conference

 

The Asian Oncology Society 1st Virtual International Conference
Z

Imatinib for CML: Can We Achieve CCyR in All Stages? Can We Prolong EFS With Imatinib Mesylate in Chronic Phase? Does QoL Improve After 1L Treatment? Experience from a Developing Country

By The Asian Oncology Society 1st Virtual International Conference FEATURING Zeba Aziz
By The Asian Oncology Society 1st Virtual International Conference FEATURING Zeba Aziz
70 views
February 25, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Featured Video

19:51
AstraZeneca Oncology

Management Strategies for Fatigue and Asthenia in First-line Mainten…

Feat. D. Czel, C. Arn
Hematologic Oncology
15:18
The Asian Oncology Society 1st Virtual International Conference

Whole Course Management of Chemo-Induced Thrombocytopenia: How Do We…

Feat. Z. Lingyun
17:53
The Asian Oncology Society 1st Virtual International Conference

Imatinib for CML: Can We Achieve CCyR in All Stages? Can We Prolong …

Feat. Z. Aziz